US President Obama urges bipartisan cooperation on health care reform plan to House Republicans

1 February 2010

In remarks at the House Republican Issues Conference on January 29, US President Barack Obama praised the Bipartisan Policy Center's (BPC) plan for reforming health care, entitled: "Crossing Our Lines: Working Together to Reform the US Health System," as a bipartisan health care proposal that is worthy of consideration by both Republicans and Democrats.

According to President Obama, the plan, which was developed by former US Senate Majority Leaders Howard Baker, Tom Daschle and Bob Dole, members of the BPC's Advisory Board and Leaders' Project on the State of American Health Care, is "pretty similar" to the legislation currently being considered by Congress. The President urged bipartisan cooperation in reforming the US health care system and said, "We've got to close the gap a little bit between the rhetoric and the reality."

The comments come after the President's State of the Union message last week when, following a setback to is hopes for health care reform due to a defeat in a Senate election in Massachusetts, he refocused his priorities on employment (The Pharma Letters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical